Researchers in the UK think this clinical experiment might considerably enhance therapy for people with blood diseases and uncommon blood types. This clinical trial involved transfusing lab-created blood into humans for the first time in history.
According to a BBC story, the initial step of the research involved giving two UK patients a few spoonfuls of lab-grown blood to test how their bodies would respond and how the blood would function.
Ten healthy volunteers will now participate in the test, giving their blood for a few months. The goal of the research is to comprehend how long these blood cells live in comparison to real red blood cells that are implanted into individuals.
The project’s experts made it clear that they did not want to take the place of donations of human blood. They said that the majority of transfusions would always rely on unpaid blood donations from average people. They clarified that the major objective of the research was to create unusual blood types, which are often hard to get.
The research, according to Dr. Farrukh Shah, medical director of transfusion at NHS Blood and Transplant, is laying the groundwork for “the production of red blood cells that may be utilized to transfuse individuals with illnesses like the sickle cell in a safe manner.”
He told that “the potential for this study to aid hard-to-transfuse patients is really big.”
NHS Blood and Transplant, as well as scientists from Bristol, Cambridge, and London, oversaw the experiment.
To read our blog on “Researchers find a new set of blood groups,” click here
